409406007: bevacizumab (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\inhibiteur de l'angiogenèse\bevacizumab
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)\bevacizumab

\Drug or medicament (substance)\Antineoplastic agent (substance)\bevacizumab
\Drug or medicament (substance)\Monoclonal antibody (substance)\bevacizumab

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody (substance)\bevacizumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody (substance)\bevacizumab

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody (substance)\bevacizumab
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody (substance)\bevacizumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

193131000077112 bevacizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

2464857019 Bevacizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2471192013 Bevacizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

469811000077113 bevacizumab (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

794791000172111 bévacizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
bevacizumab	Has disposition (attribute)	Vascular endothelial growth factor receptor antagonist (disposition)	true	Inferred relationship	Some
bevacizumab	est un(e) (attribut)	Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some
bevacizumab	est un(e) (attribut)	Monoclonal antibody agent (substance)	false	Inferred relationship	Some
bevacizumab	est un(e) (attribut)	inhibiteur de l'angiogenèse	true	Inferred relationship	Some
bevacizumab	est un(e) (attribut)	Monoclonal antibody (substance)	true	Inferred relationship	Some
bevacizumab	Has disposition (attribute)	Angiogenesis inhibitor (disposition)	true	Inferred relationship	Some
bevacizumab	est un(e) (attribut)	Antineoplastic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bevacizumab only product	a pour principe actif (attribut)	True	bevacizumab	Inferred relationship	Some	1
Product containing only bevacizumab in parenteral dose form (medicinal product form)	a pour principe actif (attribut)	True	bevacizumab	Inferred relationship	Some	1
Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	bevacizumab	Inferred relationship	Some	1
Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	bevacizumab	Inferred relationship	Some	1
Product containing bevacizumab (medicinal product)	a pour principe actif (attribut)	True	bevacizumab	Inferred relationship	Some	1
Bevacizumab 25mg/mL injection solution 4mL vial (product)	a pour principe actif (attribut)	False	bevacizumab	Inferred relationship	Some
Bevacizumab 25mg/mL injection solution 16mL vial (product)	a pour principe actif (attribut)	False	bevacizumab	Inferred relationship	Some
Product containing bevacizumab in parenteral dose form (medicinal product form)	a pour principe actif (attribut)	True	bevacizumab	Inferred relationship	Some	1
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial (clinical drug)	Has basis of strength substance (attribute)	False	bevacizumab	Inferred relationship	Some	1
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial (clinical drug)	Has precise active ingredient	False	bevacizumab	Inferred relationship	Some	1
Bevacizumab 100 mg/4 mL solution for injection vial	Has basis of strength substance (attribute)	False	bevacizumab	Inferred relationship	Some	1
Bevacizumab 100 mg/4 mL solution for injection vial	Has precise active ingredient	False	bevacizumab	Inferred relationship	Some	1

This concept is not in any reference sets